Your browser doesn't support javascript.
Stem Cell Therapy: A Promising Approach in Treatment of COVID-19.
Abbaspanah, Bahareh; Abroun, Saeid; Zarrabi, Morteza; Mozdgir, Ashkan; Mollanouri, Mohammad.
  • Abbaspanah B; Cord Blood Bank, Royan Stem Cell Technology Company, Tehran, Iran.
  • Abroun S; Cord Blood Bank, Royan Stem Cell Technology Company, Tehran, Iran.
  • Zarrabi M; Cord Blood Bank, Royan Stem Cell Technology Company, Tehran, Iran.
  • Mozdgir A; Cord Blood Bank, Royan Stem Cell Technology Company, Tehran, Iran.
  • Mollanouri M; Cord Blood Bank, Royan Stem Cell Technology Company, Tehran, Iran.
Curr Stem Cell Res Ther ; 16(4): 406-413, 2021.
Article in English | MEDLINE | ID: covidwho-1435705
ABSTRACT
COVID-19 pandemic is a global health crisis of the 21st Century. There are currently no approved vaccines and no particular anti-viral treatment for coronavirus disease. As COVID-19 has a broad range of illnesses, it is necessary to find a safe and effective therapeutic method for COVID-19. An attractive approach for treating COVID-19 is cell therapy. Cell therapy aims to inject new and healthy stem cells into a patient's body, to repair the damaged cells and tissues. Stem cell therapy is one of the most studied and important approaches in the treatment of COVID-19 these days. The significant clinical outcome was observed by the adoptive transfer of stem cells, specifically mesenchymal stem cells. This study reviews the characteristics of stem cells and clinical trials that have used stem cells in treating COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mesenchymal Stem Cells / Cell- and Tissue-Based Therapy / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Curr Stem Cell Res Ther Journal subject: Therapeutics Year: 2021 Document Type: Article Affiliation country: 1574888X15666201012165700

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Mesenchymal Stem Cells / Cell- and Tissue-Based Therapy / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Curr Stem Cell Res Ther Journal subject: Therapeutics Year: 2021 Document Type: Article Affiliation country: 1574888X15666201012165700